0001209191-19-037780.txt : 20190618 0001209191-19-037780.hdr.sgml : 20190618 20190618175655 ACCESSION NUMBER: 0001209191-19-037780 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190614 FILED AS OF DATE: 20190618 DATE AS OF CHANGE: 20190618 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRAHAM GINGER L CENTRAL INDEX KEY: 0001192601 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51541 FILM NUMBER: 19904606 MAIL ADDRESS: STREET 1: AMYLIN PHARMACEUTICALS, INC. STREET 2: 885 ARAPAHOE AVENUE CITY: BOULDER STATE: CO ZIP: 80302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOMIC HEALTH INC CENTRAL INDEX KEY: 0001131324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770552594 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-556-9300 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-14 0 0001131324 GENOMIC HEALTH INC GHDX 0001192601 GRAHAM GINGER L 1108 NORTH LEMAY AVENUE FORT COLLINS CO 80524 1 0 0 0 Common Stock 2019-06-14 4 A 0 955 0.00 A 52907 I Held by the GInger L. Graham Revocable Trust Director Stock Option (right to buy) 52.41 2019-06-14 4 A 0 6583 0.00 A 2020-06-14 2029-06-14 Common Stock 6583 6583 D Restricted stock units (RSUs) awarded on June 14, 2019 which vest in full on the first anniversary date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the RSUs become fully vested in the event of a change in control of the Company. The option becomes exercisable in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the options become fully vested in the event of a change in control of the Company. /s/ Jason W. Radford, Attorney-in-fact 2019-06-18